Lindsay A Uribe1, Peter Bacchetti2, Nicholas Gelman1, Esteban Burchard1, Mark Fitch3, Marc Hellerstein3, Mandana Khalili1. 1. Department of Medicine, University of California, San Francisco, San Francisco, California. 2. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. 3. Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California.
Abstract
BACKGROUND: Insulin resistance (IR) is associated with hepatitis C virus (HCV), and Latinos are both at risk of IR and are disproportionately affected by HCV. Moderate alcohol consumption improves insulin sensitivity and may modify HCV-associated IR. We investigated the impact of moderate alcohol discontinuation on insulin sensitivity and secretion in Latinos using direct measurements. METHODS: Twenty-five nondiabetic, noncirrhotic Latino adults without (n = 17) or with (n = 8) HCV underwent 3-day metabolic assessment before and after prescription of 6 weeks of moderate alcohol discontinuation. Peripheral IR was measured via steady-state plasma glucose (SSPG) and hepatic IR using endogenous glucose production during a 2-step 240-minute insulin suppression test. Insulin secretion was measured using graded glucose infusion test. RESULTS: Baseline mean age was 46 ± 11 years, 63% male, 29% had HCV, and mean body mass index was 27 ± 4 kg/m2 . Compared to non-HCV, HCV patients had a higher median SSPG (132 vs. 98.8 mg/dl, p = 1.0), hepatic IR (13.5 vs. 11.3, p = 0.24), and insulin secretion rate (ISR-AUC, 1,290 vs. 1,250 pmol/min, p = 0.98). After confirmed alcohol discontinuation, hepatic IR was the only parameter that changed significantly (increased, mean change 2.6 ± 4.8, p = 0.02). Higher baseline alanine aminotransferase (ALT) was also associated with a greater change in hepatic IR (average 4.0 points/ALT doubling, p = 0.004), and HCV was associated with a lesser change (average -7.3 points, p = 0.002), independent of ALT. CONCLUSIONS: Short-term moderate alcohol discontinuation adversely impacted hepatic IR in Latinos which was influenced by level of ALT at baseline independent of etiology. Although reduction in ALT through weight loss and HCV eradication remains a priority in improving IR, the observed nonharmful effect of moderate alcohol use represents a potentially confounding variable that warrants further study.
BACKGROUND:Insulin resistance (IR) is associated with hepatitis C virus (HCV), and Latinos are both at risk of IR and are disproportionately affected by HCV. Moderate alcohol consumption improves insulin sensitivity and may modify HCV-associated IR. We investigated the impact of moderate alcohol discontinuation on insulin sensitivity and secretion in Latinos using direct measurements. METHODS: Twenty-five nondiabetic, noncirrhotic Latino adults without (n = 17) or with (n = 8) HCV underwent 3-day metabolic assessment before and after prescription of 6 weeks of moderate alcohol discontinuation. Peripheral IR was measured via steady-state plasma glucose (SSPG) and hepatic IR using endogenous glucose production during a 2-step 240-minute insulin suppression test. Insulin secretion was measured using graded glucose infusion test. RESULTS: Baseline mean age was 46 ± 11 years, 63% male, 29% had HCV, and mean body mass index was 27 ± 4 kg/m2 . Compared to non-HCV, HCVpatients had a higher median SSPG (132 vs. 98.8 mg/dl, p = 1.0), hepatic IR (13.5 vs. 11.3, p = 0.24), and insulin secretion rate (ISR-AUC, 1,290 vs. 1,250 pmol/min, p = 0.98). After confirmed alcohol discontinuation, hepatic IR was the only parameter that changed significantly (increased, mean change 2.6 ± 4.8, p = 0.02). Higher baseline alanine aminotransferase (ALT) was also associated with a greater change in hepatic IR (average 4.0 points/ALT doubling, p = 0.004), and HCV was associated with a lesser change (average -7.3 points, p = 0.002), independent of ALT. CONCLUSIONS: Short-term moderate alcohol discontinuation adversely impacted hepatic IR in Latinos which was influenced by level of ALT at baseline independent of etiology. Although reduction in ALT through weight loss and HCV eradication remains a priority in improving IR, the observed nonharmful effect of moderate alcohol use represents a potentially confounding variable that warrants further study.
Authors: James R Churilla; Tammie M Johnson; Rebecca Curls; Michael R Richardson; William R Boyer; Stephanie R Devore; Albatool H Alnojeidi Journal: Diabetes Metab Syndr Date: 2014-05-24
Authors: Lando L J Koppes; Jacqueline M Dekker; Henk F J Hendriks; Lex M Bouter; Robert J Heine Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Kerry-Lee Milner; David van der Poorten; Michael Trenell; Arthur B Jenkins; Aimin Xu; George Smythe; Gregory J Dore; Amany Zekry; Martin Weltman; Vincent Fragomeli; Jacob George; Donald J Chisholm Journal: Gastroenterology Date: 2009-12-04 Impact factor: 22.682
Authors: Joline W J Beulens; Eric B Rimm; Henk F J Hendriks; Frank B Hu; JoAnn E Manson; David J Hunter; Kenneth J Mukamal Journal: Diabetes Date: 2007-06-11 Impact factor: 9.461
Authors: A Poli; F Marangoni; A Avogaro; G Barba; S Bellentani; M Bucci; R Cambieri; A L Catapano; S Costanzo; C Cricelli; G de Gaetano; A Di Castelnuovo; P Faggiano; F Fattirolli; L Fontana; G Forlani; S Frattini; R Giacco; C La Vecchia; L Lazzaretto; L Loffredo; L Lucchin; G Marelli; W Marrocco; S Minisola; M Musicco; S Novo; C Nozzoli; C Pelucchi; L Perri; F Pieralli; D Rizzoni; R Sterzi; R Vettor; F Violi; F Visioli Journal: Nutr Metab Cardiovasc Dis Date: 2013-05-01 Impact factor: 4.222
Authors: Rebecca G Kim; Jonathan Kramer-Feldman; Peter Bacchetti; Barbara Grimes; Esteban Burchard; Celeste Eng; Donglei Hu; Marc Hellerstein; Mandana Khalili Journal: Alcohol Clin Exp Res Date: 2021-11-23 Impact factor: 3.455